Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients: a Multicenter Randomized, Double-blind, Placebo Controlled, Superiority Trial

NCT04673422 is registered in ClinicalTrials.gov with Phramongkutklao College of Medicine and Hospital as lead sponsor.

NCT NCT04673422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04673422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients: a Multicenter Randomized, Double-blind, Placebo Controlled, Superiority Trial
Lead sponsor
Phramongkutklao College of Medicine and Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
January 15, 2021
Completion date
June 17, 2023
Enrollment
358 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dengue, dengue shock syndrome, dengue with warning signs